|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Rebetol (Ribavirin). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (547)
Cases resulting in a serious event (545)
Cases resulting in death (35)
Cases resulting in life threatening events (32)
Cases resulting in hospitalization (291)
Cases resulting in disability (36)
Cases resulting in other serious reactions (302)
Below is a sample of reports where side effects / adverse reactions may be related to Rebetol (Ribavirin). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in 55 year old male receiving Rebetol (Ribavirin)
Reported by a physician from Japan on 2007-10-31
Patient: 55 year old male
Adverse reactions / side effects: Haemoglobin Decreased, Cellulitis, Vitreous Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: 100 mcg qw sc
Indication: Hepatitis C
Start date: 2006-03-13
End date: 2006-12-27
Rebetol
Dosage: 600 mg qd po ; 500 mg qd po ; 400 mg qd po ; 600 mg qd po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-03-13
End date: 2006-04-26
Rebetol
Dosage: 600 mg qd po ; 500 mg qd po ; 400 mg qd po ; 600 mg qd po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-04-27
End date: 2006-05-10
Rebetol
Dosage: 600 mg qd po ; 500 mg qd po ; 400 mg qd po ; 600 mg qd po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-05-11
End date: 2006-06-27
Rebetol
Dosage: 600 mg qd po ; 500 mg qd po ; 400 mg qd po ; 600 mg qd po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-08-28
End date: 2007-01-03
Other drugs received by patient: Glyburide; Glucobay; Melbin; Voltaren; Jeoase; Cacelmin
Adverse event in 50 year old male receiving Rebetol (Ribavirin)
Reported by a physician from Japan on 2007-10-31
Patient: 50 year old male
Adverse reactions / side effects: Haemoptysis
Suspect drug(s):
PEG-Intron
Dosage: 100 mg qw sc
Indication: Hepatitis C
Start date: 2007-09-21
Rebetol
Dosage: 800 mg qd po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-09-21
Other drugs received by patient: Urso 250; Glycyron
Adverse event in 49 year old female receiving Rebetol (Ribavirin)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: 49 year old female, weighing 74.8 kg (164.7 pounds)
Adverse reactions / side effects: Agitation, Oral Intake Reduced, Drug Ineffective, Visual Acuity Reduced, Headache, Pyrexia, Constipation, Fall, Abdominal Discomfort, Fatigue, Photophobia, Abdominal Distension, Depression, Vomiting, Nausea, Paraesthesia, Haematochezia, Insomnia, Alopecia, Dehydration, Anorexia, Memory Impairment, Lacrimation Increased, Asthenia
Suspect drug(s):
PEG-Intron
Dosage: 120 mcg;qw;sc
Indication: Hepatitis C
Start date: 2007-08-07
Rebetol
Dosage: 1000 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-08-07
Other drugs received by patient: Laxatives
Adverse event in female receiving Rebetol (Ribavirin)
Reported by a physician from United States on 2007-10-30
Patient: female, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Dyspnoea
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Indication: Hepatitis C
Start date: 2007-06-04
End date: 2007-07-30
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-06-04
End date: 2007-08-03
Other drugs received by patient: Imodium; Ibuprofen; Ibuprofen; Multi-Vitamins; Nicoderm; Modafinil; Zyrtec; Cymbalta; Propranolol; Propranolol; Conjugated Estrogens; Lisinopril; Nexium; Eszopiclone; Propoxyphene Hydrochloride; Skelaxin; Balsalazide Disodium; Imitrex; Promethazine HCL
Adverse event in 38 year old male receiving Rebetol (Ribavirin)
Reported by a physician from Japan on 2007-10-29
Patient: 38 year old male
Adverse reactions / side effects: Autoimmune Hepatitis, Hepatitis C RNA Positive, Condition Aggravated, Chronic Hepatitis, Liver Disorder
Suspect drug(s):
PEG-Intron
Dosage: ; qw; sc
Indication: Hepatitis C
Start date: 2004-12-16
End date: 2005-06-20
Peginterferon Alfa-2A (Peginterferon Alfa-2A)
Indication: Hepatitis C
Start date: 2005-01-01
End date: 2006-01-01
Rebetol
Dosage: ; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2004-12-16
End date: 2005-06-20
Adverse event in 59 year old female receiving Rebetol (Ribavirin)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: 59 year old female, weighing 72.6 kg (159.7 pounds)
Adverse reactions / side effects: Agitation, Oral Intake Reduced, Performance Status Decreased, Weight Decreased, Headache, Constipation, Oral Herpes, Impaired Driving Ability, Hot Flush, Malaise, Road Traffic Accident, Anger, Vomiting, Anaemia, Condition Aggravated, Cystitis, Emotional Distress, Incoherent, Dysuria, Insomnia, Dehydration, Hypertension, Aphonia, Influenza Like Illness
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: sc
Indication: Hepatitis C
Start date: 2007-05-01
End date: 2007-08-16
Rebetol
Dosage: po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-05-01
End date: 2007-08-16
Adverse event in 51 year old female receiving Rebetol (Ribavirin)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: 51 year old female, weighing 81.6 kg (179.6 pounds)
Adverse reactions / side effects: Weight Decreased, Hepatic Pain, Vomiting, Nausea, Pain in Extremity, Pain, Pleurisy, Hepatic Neoplasm, Food Aversion, Weight Fluctuation, Decreased Appetite, Influenza Like Illness
Suspect drug(s):
PEG-Intron
Dosage: ; sc
Indication: Hepatitis C
Start date: 2007-07-06
Rebetol
Dosage: ; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-07-06
Adverse event in 60 year old male receiving Rebetol (Ribavirin)
Reported by a physician from Japan on 2007-10-29
Patient: 60 year old male
Adverse reactions / side effects: Autoimmune Disorder, Hepatic Function Abnormal, Drug Hypersensitivity, Oedema Peripheral, Platelet Count Decreased, Pleural Effusion, Transaminases Increased, Ascites
Adverse event resulted in: hospitalization
Suspect drug(s):
Intron A
Dosage: 10 miu; im
Indication: Hepatitis C
PEG-Intron
Dosage: 100 mcg; qw; sc
Indication: Hepatitis C
Start date: 2006-01-01
Rebetol
Dosage: po; 800 mg; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-01-01
Other drugs received by patient: Stronger NEO Minophagen C
Adverse event in 60 year old female receiving Rebetol (Ribavirin)
Reported by a physician from United States on 2007-10-29
Patient: 60 year old female, weighing 63.5 kg (139.7 pounds)
Adverse reactions / side effects: Peritonitis Bacterial
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: 30 mcg;qw;sc
Indication: Hepatitis C
Start date: 2007-09-18
End date: 2007-10-17
Procrit
Dosage: 40000 iu;qw;sc
Indication: Anaemia
Start date: 2007-10-09
End date: 2007-10-17
Rebetol
Dosage: 600 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-09-18
End date: 2007-10-17
Other drugs received by patient: Lasix; Aldactone; Qualaquin; Aciphex; Clonipine; Milk Thistle
Adverse event in male receiving Rebetol (Ribavirin)
Reported by a physician from United States on 2007-10-29
Patient: male, weighing 72.2 kg (158.8 pounds)
Adverse reactions / side effects: Hepatic Enzyme Increased
Suspect drug(s):
HCV-796
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-12-27
End date: 2007-08-10
Peginterferon Alfa-2B
Indication: Hepatitis C
Start date: 2006-12-27
End date: 2007-08-28
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-12-27
End date: 2007-08-28
Other drugs received by patient: Effexor; Iron; Riboflavin TAB; Metronidazole; Vitamin B; Acetaminophen
Adverse event in 65 year old male receiving Rebetol (Ribavirin)
Reported by a physician from Japan on 2007-10-29
Patient: 65 year old male, weighing 62.0 kg (136.4 pounds)
Adverse reactions / side effects: Pancreatitis Acute, Lupus-Like Syndrome, Disseminated Intravascular Coagulation, Glomerulonephritis Membranoproliferative, Cholestasis, Hepatic Failure, Serositis, Bone Marrow Failure, Pulmonary Alveolar Haemorrhage, Anaemia, Condition Aggravated, Autoimmune Disorder, Renal Failure, Respiratory Failure, Sepsis, Insomnia, Systemic Lupus Erythematosus, NO Therapeutic Response, Lupus Nephritis
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Suspect drug(s):
PEG-Intron
Dosage: 100 mcg;qw;sc
Indication: Hepatitis C
Start date: 2005-03-09
End date: 2005-12-20
Rebetol
Dosage: 600 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2005-03-09
End date: 2005-12-26
Other drugs received by patient: Urso 250
Adverse event in 56 year old female receiving Rebetol (Ribavirin)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: 56 year old female, weighing 55.8 kg (122.7 pounds)
Adverse reactions / side effects: Dysgeusia, Weight Decreased, Malaise, Euphoric Mood, Retching, Dehydration, Memory Impairment, Influenza Like Illness
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: 120 mcg;qw
Indication: Hepatitis C
Start date: 2007-04-03
End date: 2007-04-17
Rebetol
Dosage: 200 mg;bid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-04-03
End date: 2007-04-17
Adverse event in male receiving Rebetol (Ribavirin)
Reported by a physician from United States on 2007-10-29
Patient: male, weighing 116.0 kg (255.2 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
Adverse event resulted in: disablity
Suspect drug(s):
HCV-796
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-02-22
End date: 2007-07-03
PEG-Intron
Indication: Hepatitis C
Start date: 2007-02-22
End date: 2007-07-03
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-02-22
End date: 2007-03-21
Rebetol
Administration route: Oral
Start date: 2007-03-21
End date: 2007-07-09
Other drugs received by patient: Omeprazole; Allopurinol; Compazine; Compazine; Levothyroxine Sodium; Lorazepam; Folic Acid; Fentanyl Citrate; Atenolol
Adverse event in 57 year old male receiving Rebetol (Ribavirin)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-26
Patient: 57 year old male
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Vomiting, Nausea, Alanine Aminotransferase Increased, Blood Albumin Increased, Fatigue, Aspartate Aminotransferase Increased
Adverse event resulted in: disablity
Suspect drug(s):
HCV-796
Dosage: 500 mg;bid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-03-13
End date: 2007-06-26
PEG-Intron (Peginterron Alfa-2B)
Dosage: 120 mcg;qw; sc
Indication: Hepatitis C
Start date: 2007-03-13
End date: 2007-06-26
Rebetol
Dosage: 140 0mg;qd;po; 1000 mg;qd;po; 800 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-03-13
End date: 2007-03-25
Rebetol
Dosage: 140 0mg;qd;po; 1000 mg;qd;po; 800 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-03-13
End date: 2007-06-26
Rebetol
Dosage: 140 0mg;qd;po; 1000 mg;qd;po; 800 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-03-26
End date: 2007-06-26
Rebetol
Indication: Hepatitis C
Other drugs received by patient: Vicodin; Folic Acid; Advil; Albuterol; Youngevity Vitamin Supplements with Selenium
Adverse event in 48 year old male receiving Rebetol (Ribavirin)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-26
Patient: 48 year old male
Adverse reactions / side effects: Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Ocular Icterus, Hepatic Enzyme Increased
Suspect drug(s):
HCV-796
Dosage: 1000 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-12-27
End date: 2007-08-10
PEG-Intron
Dosage: 120 mcg;qw;sc
Indication: Hepatitis C
Start date: 2006-12-27
End date: 2007-08-28
Rebetol
Dosage: 1000 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-12-27
End date: 2007-08-28
Other drugs received by patient: Effexor (Con.); Acetaminophen (Con.); Riboflavin (Con.); Vitamin B (Con.); Iron (Con.); Metronidazole (Con.)
Adverse event in 50 year old female receiving Rebetol (Ribavirin)
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: 50 year old female
Adverse reactions / side effects: Oral Mucosal Blistering, White Blood Cell Count Decreased, Pruritus, Neoplasm Malignant, Impaired Healing, Skin Necrosis, Erythema, Blister
Suspect drug(s):
PEG-Intron
Dosage: 120 mcg;
Indication: Hepatitis C
Start date: 2007-06-01
Rebetol
Dosage: 1000 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-06-01
Adverse event in 44 year old female receiving Rebetol (Ribavirin)
Reported by a physician from France on 2007-10-26
Patient: 44 year old female
Adverse reactions / side effects: Drug Ineffective, Menopause
Suspect drug(s):
Rebetol
Indication: Hepatitis C
Viraferonpeg
Dosage: sc
Indication: Hepatitis C
Adverse event in 47 year old male receiving Rebetol (Ribavirin)
Reported by a consumer/non-health professional from United States on 2007-10-25
Patient: 47 year old male
Adverse reactions / side effects: White Blood Cell Count Decreased, RED Blood Cell Count Decreased, Haematemesis, Influenza Like Illness
Suspect drug(s):
PEG-Intron
Dosage: ; sc
Indication: Hepatitis C
Rebetol
Dosage: ; po
Administration route: Oral
Indication: Hepatitis C
Adverse event in 67 year old male receiving Rebetol (Ribavirin)
Reported by a physician from Japan on 2007-10-25
Patient: 67 year old male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Acute Pulmonary Oedema, Pneumonia, Anaemia, Hepatic Failure, Condition Aggravated, Blood Beta-D-Glucan Increased, Hepatic Atrophy, Respiratory Failure, Staphylococcal Infection, Blood Culture Positive, Sepsis, Acute Respiratory Distress Syndrome, Cytomegalovirus Infection, Platelet Count Decreased, Enteritis Infectious, Infection
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
PEG-Intron
Dosage: 80 mcg; qw; sc; 50 mcg; qw; sc; 40 mcg; qw; sc
Indication: Hepatitis C
Start date: 2006-03-13
End date: 2006-03-20
PEG-Intron
Dosage: 80 mcg; qw; sc; 50 mcg; qw; sc; 40 mcg; qw; sc
Indication: Hepatitis C
Start date: 2006-03-27
End date: 2006-04-03
PEG-Intron
Dosage: 80 mcg; qw; sc; 50 mcg; qw; sc; 40 mcg; qw; sc
Indication: Hepatitis C
Start date: 2006-04-10
End date: 2006-12-19
Rebetol
Dosage: 800 mg; qd; po; 600 mg; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-03-13
End date: 2006-03-26
Rebetol
Dosage: 800 mg; qd; po; 600 mg; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-03-27
End date: 2006-12-26
Adverse event in 42 year old female receiving Rebetol (Ribavirin)
Reported by a physician from United States on 2007-10-25
Patient: 42 year old female, weighing 65.8 kg (144.7 pounds)
Adverse reactions / side effects: Lymphadenopathy, Blood Count Abnormal, Cyst, Rheumatoid Arthritis, Haemangioma of Liver, Blood Immunoglobulin G Increased, Auricular Swelling, Balance Disorder, Agnosia, Palpitations, Oedema Peripheral, Muscle Injury, DRY Mouth, Otorrhoea, Raynaud's Phenomenon, Subcutaneous Abscess, Tongue DRY, Pancytopenia, Autoimmune Disorder, Antinuclear Antibody Positive, Temporomandibular Joint Syndrome, Staphylococcal Infection, Activities of Daily Living Impaired, Swelling, Systemic Lupus Erythematosus, Vision Blurred, Angiopathy, Photosensitivity Reaction, Extensor Plantar Response, Fall, Muscle Strain, Poor Quality Sleep, Joint Range of Motion Decreased, Chest Pain, Oedema, Musculoskeletal Stiffness, Cryoglobulinaemia, Injury, Depression, Splenomegaly, Eye Disorder, Neuropathy, Dyspnoea, Musculoskeletal Pain, Dysstasia, Arthralgia, Sinus Disorder, Alopecia, Viral Pharyngitis, Blood Disorder, Gait Disturbance, Asthenia, RED Blood Cell Sedimentation Rate Increased, Immobile, Night Sweats, Sciatica, Deafness, Visual Acuity Reduced, Thirst, Headache, Erythema, Tendon Injury, Connective Tissue Disorder, Coeliac Disease, Dyspepsia, Tendonitis, Stress Urinary Incontinence, Nerve Root Compression, Muscle Spasms, Cervical Polyp, Epistaxis, Myositis, Intervertebral Disc Protrusion, Viral Load Increased, Rheumatoid Factor Positive, Dysphagia, Pain in Extremity, Acne, Hypoaesthesia, Metrorrhagia, Paraesthesia, Joint Swelling, Tendon Disorder, Dehydration, Nervous System Disorder, Mental Disorder, Ear Pain, Vasculitis, Cardiovascular Disorder, Neuralgia, Nerve Injury, Confusional State, Tendon Rupture, Drug Ineffective, Pain, Hypokalaemia, Polyneuropathy, Diplopia, Hand Deformity, Myalgia, Joint Crepitation, Fatigue, Skin Discolouration, Fibromyalgia, Intervertebral Disc Disorder, Staphylococcal Abscess, Pharyngolaryngeal Pain, Dizziness, Protein Total Increased, Sinusitis, Pathogen Resistance, Pain in JAW, Guillain-Barre Syndrome, Haemoptysis, Motor Dysfunction, Synovitis, Condition Aggravated, Swollen Tongue, Cognitive Disorder, Cervicobrachial Syndrome, Deformity, Muscle Twitching, Amnesia, Rash Macular, Osteoarthritis, Bronchitis, Spinal Cord Disorder, Influenza Like Illness, Inflammation
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
PEG-Intron
Dosage: 96 mcg; qw; sc
Indication: Hepatitis C
Start date: 2002-03-01
End date: 2002-06-14
Rebetol
Dosage: 800 mg; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2002-03-01
End date: 2002-06-14
Other drugs received by patient: Norco; Folic Acid; Celexa; Dalmane; Zoloft; Norflex; Cephalexin; Neurontin; Prednisone TAB; Cyclobenzaprine HCL; Remeron; Prednisone TAB; Promethazine; Furosemide; Vioxx; Amitriptyline HCL; Sonata; Zyprexa; Effexor XR; Trimox (Sulfamethoxazole / Trimethoprim); Tramadol HCL; Trazodone HCL; Lyrica; Fentanyl; Nortriptyline HCL; Anaprox
Adverse event in 48 year old female receiving Rebetol (Ribavirin)
Reported by a consumer/non-health professional from United States on 2007-10-24
Patient: 48 year old female
Adverse reactions / side effects: Migraine, Panic Attack, Sleep Disorder, Diarrhoea, Hallucination, Auditory, Dehydration, Dizziness, Influenza Like Illness
Suspect drug(s):
PEG-Intron
Indication: Hepatitis C
Start date: 2007-09-10
Rebetol
Dosage: po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-09-10
Adverse event in 49 year old male receiving Rebetol (Ribavirin)
Reported by a consumer/non-health professional from United States on 2007-10-24
Patient: 49 year old male, weighing 86.2 kg (189.6 pounds)
Adverse reactions / side effects: Eye Irritation, Schizophrenia, Headache, Hyperhidrosis, Delusion, Mania, Thinking Abnormal, Fatigue, Neck Pain, Palpitations, Depression, Blood Sodium Decreased, Localised Infection, Back Pain, Vomiting, Mydriasis, Nausea, Paranoia, DRY Skin, Convulsion, Bipolar Disorder, Hyperphagia, Insomnia, Thyroid Disorder, Feeling Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: ; sc
Indication: Hepatitis C
Start date: 2007-04-10
End date: 2007-06-04
Rebetol
Dosage: ; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-04-10
End date: 2007-06-04
Adverse event in 28 year old female receiving Rebetol (Ribavirin)
Reported by a physician from Japan on 2007-10-24
Patient: 28 year old female, weighing 49.0 kg (107.8 pounds)
Adverse reactions / side effects: Drug Exposure During Pregnancy, Transmission of Drug VIA Semen, Ovarian Neoplasm
Suspect drug(s):
PEG-Intron
Indication: Hepatitis C
Rebetol
Indication: Hepatitis C
Adverse event in female receiving Rebetol (Ribavirin)
Reported by a physician from United States on 2007-10-23
Patient: female, weighing 77.0 kg (169.4 pounds)
Adverse reactions / side effects: Abdominal Pain
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Indication: Hepatitis C
Start date: 2007-07-20
Procrit
Indication: Anaemia
Start date: 2007-07-30
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-07-21
Other drugs received by patient: Cipro; Lexapro; Ferrous Sulfate TAB; Spironolactone; Vitamin CAP; Synthroid
Adverse event in 50 year old male receiving Rebetol (Ribavirin)
Reported by a physician from Japan on 2007-10-22
Patient: 50 year old male
Adverse reactions / side effects: Malaise, Face Oedema, Dysstasia, Oedema Peripheral, Insomnia, Anaemia, Muscular Weakness, Asthenia, Candidiasis
Suspect drug(s):
PEG-Intron
Dosage: 100 mcg; qw; sc
Indication: Hepatitis C
Start date: 2006-11-14
End date: 2007-04-24
Rebetol
Dosage: 800 mg; qd; po, 600 mg; qd; po, 400 mg; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-11-14
End date: 2006-12-11
Rebetol
Dosage: 800 mg; qd; po, 600 mg; qd; po, 400 mg; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-12-12
End date: 2006-12-18
Rebetol
Dosage: 800 mg; qd; po, 600 mg; qd; po, 400 mg; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-12-19
End date: 2007-04-24
|
